ProKidney Corp. logo

ProKidney Corp.

PROK | NASDAQ
Chart Builder DCF Calculator
$1.77
-$0.14 (-7.33%)
At close: Sep 21, 2026, 4:00 PM ET
$1.77
$0 (0.00%)
Pre-market: Sep 22, 2026, 4:00 AM ET

Market Data

Market Cap
$642.24M
Enterprise Value
$417.68M
Beta
1.75
Average Volume
1.13M
Shares Outstanding (Diluted)
186.56M
Shares Change YoY
42.71%
Institutional Ownership
30.05%
Exchange
NASDAQ
ISIN
US74291D1046

Price Performance

Price Change 1M
11.3%
Price Change 3M
-1.7%
Price Change 6M
-3.3%
Price Change YTD
-20.6%
Price Change 1Y
-37.0%
Price Change 3Y
-63.4%
Price Change 5Y
-81.9%
1M CAGR (ann.)
16.5%
1Y CAGR (ann.)
-24.5%
5Y CAGR (ann.)
-27.9%
All-Time CAGR
-27.3%

Valuation

PE Ratio
-3.11
Forward PE
N/A
PEG Ratio
3.80
Forward PEG
-3.73
PS Ratio
729.65
Forward PS
1,449.30
PB Ratio
2.68
P/FCF Ratio
-3.74
P/Adj. FCF Ratio
-3.39
P/OCF Ratio
-2.33
EV/Sales
510.61
EV/EBIT
-2.50
EV/EBITDA
-2.60
EV/FCF
-2.61
Earnings Yield
-32.2%
FCF Yield
-26.8%
Adj. FCF Yield
-29.5%

Financial Health

Net Cash
$179.17M
Total Debt
$2.39M
Cash & Short-Term Investments
$181.56M
Total Assets
$249.02M
Current Ratio
8.36
Quick Ratio
8.36
Debt / Equity Ratio
-0.00
Debt / EBITDA
-0.01
Debt / FCF
-0.02
OCF / Debt
-58.97
Interest Coverage
-9,327.16
Altman Z-Score
5.91
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
-252.6%
Operating Profit Margin
-21664.5%
EBITDA Margin
-19651.8%
Net Profit Margin
-10599.8%
FCF Margin
-19527.4%
Adj. FCF Margin
-21513.0%
SBC / Revenue
1985.6%
SBC Impact (per share)
-10.2%

Returns

Return on Assets
-34.8%
Return on Equity
8.8%
Return on Invested Capital
-68.1%
Return on Capital Employed
-78.3%
Return on Tangible Assets
-34.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
91.2%
Revenue CAGR 5Y
80.4%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
2.6%
EPS CAGR 5Y
9.5%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
-2.1%
FCF CAGR 5Y
-11.2%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
8
EPS Growth Next 3Y
17.0%
Revenue Growth Next 3Y
439.7%
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$0.12
EPS Growth Est (next Q)
0.0%
Revenue Est (next Q)
$124.6K
Revenue Growth Est (next Q)
-42.6%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$4.67
Price Target Upside
163.8%

Cash Flow

Operating Cash Flow
$-141.17M
Free Cash Flow
$-159.73M
Adj. Free Cash Flow
$-175.98M
FCF Per Share
-$0.86
OCF Per Share
-$0.76
OCF/S Ratio
-17257.6%

Income Statement

Revenue
$818K
Gross Profit
$-2.07M
Operating Income
$-177.22M
EBITDA
$-160.75M
Net Income
$-86.71M
EPS (Diluted)
-$0.57
Revenue / Employee
$3.54K
Profit / Employee
$-375.35K
Employees
231

© 2026 bestshares.com. All rights reserved.